Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?
Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...
Hosted on MSN20d
Ozempic and Wegovy officially moved off FDA’s drug shortage list
The online company advertised its sale of compounded GLP-1 drugs in a 60-second Super Bowl ad earlier ... provide compounded semaglutide to the extent it is able. “We do compound semaglutide.
USA TODAY on MSN20d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper ...
Fierce Pharma9d
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...
Fierce Pharma7d
Texas court decision prevents compounders from producing knockoffs of Eli Lilly's tirzepatide
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Yahoo News Canada21d
Ozempic and Wegovy officially moved off FDA’s drug shortage list
The online company advertised its sale of compounded GLP-1 drugs in a 60-second Super Bowl ad earlier this month ... would continue to provide compounded semaglutide to the extent it is able. “We do ...